Serotonin in the Modulation of Neural Plasticity and Networks: Implications for Neurodevelopmental Disorders

Neuron

Volumn 76, Issue 1, 2012, Pages 175-191

  Lesch, Klaus Peter ^a,b   Waider, Jonas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GLUTAMIC ACID; METABOTROPIC RECEPTOR; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

BRAIN DEVELOPMENT; BRAIN FUNCTION; EMOTIONALITY; EPIGENETICS; HUMAN; LEARNING; MOLECULAR INTERACTION; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SOCIAL COGNITION; SOCIAL INTERACTION; SOMATOSENSORY CORTEX; SYNAPTOGENESIS;

ANIMALS; DEVELOPMENTAL DISABILITIES; HUMANS; NERVE NET; NEURONAL PLASTICITY; SEROTONIN;

EID: 84867120199     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2012.09.013     Document Type: Review

References (174)

1. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 2008, 9:341-355.
2. Albert P.R. Transcriptional regulation of the 5-HT1A receptor: implications for mental illness. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012, 367:2402-2415.
3. Amodio D.M., Frith C.D. Meeting of minds: the medial frontal cortex and social cognition. Nat. Rev. Neurosci. 2006, 7:268-277.
4. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306:879-881.
5. Auerbach B.D., Osterweil E.K., Bear M.F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011, 480:63-68.
6. Azmitia E.C., Whitaker-Azmitia P.M. Development and adult plasticity of serotonergic neurons and their target cells. Serotonergic neurons and 5-HT receptors in the CNS 1997, 1-39. Springer, Berlin, Heidelberg, New York. H.G. Baumgarten, M. Göthert (Eds.).
7. Azmitia E.C., Singh J.S., Whitaker-Azmitia P.M. Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology 2011, 60:1347-1354.
8. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
9. Barr C.S., Newman T.K., Shannon C., Parker C., Dvoskin R.L., Becker M.L., Schwandt M., Champoux M., Lesch K.P., Goldman D., et al. Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol. Psychiatry 2004, 55:733-738.
10. Bartolomucci A., Carola V., Pascucci T., Puglisi-Allegra S., Cabib S., Lesch K.P., Parmigiani S., Palanza P., Gross C. Increased vulnerability to psychosocial stress in heterozygous serotonin transporter knockout mice. Dis. Model. Mech. 2010, 3:459-470.
11. Baudry A., Mouillet-Richard S., Schneider B., Launay J.M., Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010, 329:1537-1541.
12. Becamel C., Gavarini S., Chanrion B., Alonso G., Galeotti N., Dumuis A., Bockaert J., Marin P. The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. J. Biol. Chem. 2004, 279:20257-20266.
13. Bennett A.J., Lesch K.P., Heils A., Long J.C., Lorenz J.G., Shoaf S.E., Champoux M., Suomi S.J., Linnoila M.V., Higley J.D. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol. Psychiatry 2002, 7:118-122.
14. Bennett-Clarke C.A., Chiaia N.L., Rhoades R.W. Thalamocortical afferents in rat transiently express high-affinity serotonin uptake sites. Brain Res. 1996, 733:301-306.
15. Benson D.L., Schnapp L.M., Shapiro L., Huntley G.W. Making memories stick: cell-adhesion molecules in synaptic plasticity. Trends Cell Biol. 2000, 10:473-482.
16. Bethea C.L., Reddy A.P. Effect of ovarian steroids on gene expression related to synapse assembly in serotonin neurons of macaques. J. Neurosci. Res. 2012, 90:1324-1334.
17. Bethea C.L., Reddy A.P. Ovarian steroids increase glutamatergic related gene expression in serotonin neurons of macaques. Mol. Cell. Neurosci. 2012, 49:251-262.
18. Blakemore S.J. The social brain in adolescence. Nat. Rev. Neurosci. 2008, 9:267-277.
19. Bockaert J., Perroy J., Becamel C., Marin P., Fagni L. GPCR interacting proteins (GIPs) in the nervous system: Roles in physiology and pathologies. Annu. Rev. Pharmacol. Toxicol. 2010, 50:89-109.
20. Boucard A.A., Ko J., Sudhof T.C. High affinity neurexin binding to cell adhesion G-protein-coupled receptor CIRL1/latrophilin-1 produces an intercellular adhesion complex. J. Biol. Chem. 2012, 287:9399-9413.
21. Bredt D.S., Nicoll R.A. AMPA receptor trafficking at excitatory synapses. Neuron 2003, 40:361-379.
22. Calizo L.H., Akanwa A., Ma X., Pan Y.Z., Lemos J.C., Craige C., Heemstra L.A., Beck S.G. Raphe serotonin neurons are not homogenous: electrophysiological, morphological and neurochemical evidence. Neuropharmacology 2011, 61:524-543.
23. Canli T., Lesch K.P. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat. Neurosci. 2007, 10:1103-1109.
24. Canli T., Qiu M., Omura K., Congdon E., Haas B.W., Amin Z., Herrmann M.J., Constable R.T., Lesch K.P. Neural correlates of epigenesis. Proc. Natl. Acad. Sci. USA 2006, 103:16033-16038.
25. Carola V., Frazzetto G., Pascucci T., Audero E., Puglisi-Allegra S., Cabib S., Lesch K.P., Gross C. Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol. Psychiatry 2008, 63:840-846.
26. Carr L., Iacoboni M., Dubeau M.C., Mazziotta J.C., Lenzi G.L. Neural mechanisms of empathy in humans: a relay from neural systems for imitation to limbic areas. Proc. Natl. Acad. Sci. USA 2003, 100:5497-5502.
27. Chandana S.R., Behen M.E., Juhasz C., Muzik O., Rothermel R.D., Mangner T.J., Chakraborty P.K., Chugani H.T., Chugani D.C. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Dev. Neurosci. 2005, 23:171-182.
28. Chanrion B., Mannoury la Cour C., Bertaso F., Lerner-Natoli M., Freissmuth M., Millan M.J., Bockaert J., Marin P. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc. Natl. Acad. Sci. USA 2007, 104:8119-8124.
29. Choi Y.B., Li H.L., Kassabov S.R., Jin I., Puthanveettil S.V., Karl K.A., Lu Y., Kim J.H., Bailey C.H., Kandel E.R. Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in aplysia. Neuron 2011, 70:468-481.
30. Chubykin A.A., Atasoy D., Etherton M.R., Brose N., Kavalali E.T., Gibson J.R., Sudhof T.C. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007, 54:919-931.
31. Cook E.H., Leventhal B.L. The serotonin system in autism. Curr. Opin. Pediatr. 1996, 8:348-354.
32. Cordes S.P. Molecular genetics of the early development of hindbrain serotonergic neurons. Clin. Genet. 2005, 68:487-494.
33. Cruz D.A., Eggan S.M., Azmitia E.C., Lewis D.A. Serotonin1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia. Am. J. Psychiatry 2004, 161:739-742.
34. Cubillo A., Halari R., Smith A., Taylor E., Rubia K. A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with attention deficit hyperactivity disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 2012, 48:194-215.
35. Dahlstrom A., Fuxe K. Localization of monoamines in the lower brain stem. Experientia 1964, 20:398-399.
36. Dalva M.B., McClelland A.C., Kayser M.S. Cell adhesion molecules: signalling functions at the synapse. Nat. Rev. Neurosci. 2007, 8:206-220.
37. Daubert E.A., Condron B.G. Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci. 2010, 33:424-434.
38. de Almeida J., Mengod G. Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex. J. Neurochem. 2007, 103:475-486.
39. de Almeida J., Mengod G. Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment. J. Neurochem. 2008, 107:488-496.
40. De Blasi A., Conn P.J., Pin J., Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol. Sci. 2001, 22:114-120.
41. de Wit J., Sylwestrak E., O'Sullivan M.L., Otto S., Tiglio K., Savas J.N., Yates J.R., Comoletti D., Taylor P., Ghosh A. LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation. Neuron 2009, 64:799-806.
42. de Zeeuw P., Mandl R.C., Hulshoff Pol H.E., van Engeland H., Durston S. Decreased frontostriatal microstructural organization in attention deficit/hyperactivity disorder. Hum. Brain Mapp. 2012, 33:1941-1951.
43. Derkach V.A., Oh M.C., Guire E.S., Soderling T.R. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat. Rev. Neurosci. 2007, 8:101-113.
44. Devlin B., Scherer S.W. Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev. 2012, 22:229-237.
45. Devon R.S., Anderson S., Teague P.W., Muir W.J., Murray V., Pelosi A.J., Blackwood D.H., Porteous D.J. The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol. Psychiatry 2001, 6:311-314.
46. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsater H., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 2007, 39:25-27.
47. Durand C.M., Perroy J., Loll F., Perrais D., Fagni L., Bourgeron T., Montcouquiol M., Sans N. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol. Psychiatry 2012, 17:71-84.
48. Elia J., Glessner J.T., Wang K., Takahashi N., Shtir C.J., Hadley D., Sleiman P.M.A., Zhang H., Kim C.E., Robison R., et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat. Genet. 2012, 44:78-84.
49. Erzurumlu R.S., Gaspar P. Development and critical period plasticity of the barrel cortex. Eur. J. Neurosci. 2012, 35:1540-1553.
50. Etherton M.R., Blaiss C.A., Powell C.M., Sudhof T.C. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl. Acad. Sci. USA 2009, 106:17998-18003.
51. Fagni L., Bertaso F., Perroy J., Ango F. Unexpected roles of scaffolding proteins in receptor patho-physiological functions. J. Integr. Neurosci. 2008, 7:211-224.
52. Frith C.D., Frith U. Mechanisms of social cognition. Annu. Rev. Psychol. 2012, 63:287-313.
53. Frith C.D., Singer T. The role of social cognition in decision making. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3875-3886.
54. Fu W., Le Maitre E., Fabre V., Bernard J.F., David Xu Z.Q., Hokfelt T. Chemical neuroanatomy of the dorsal raphe nucleus and adjacent structures of the mouse brain. J. Comp. Neurol. 2010, 518:3464-3494.
55. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4:1002-1012.
56. Gerstein M.B., Kundaje A., Hariharan M., Landt S.G., Yan K.K., Cheng C., Mu X.J., Khurana E., Rozowsky J., Alexander R., et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012, 489:91-100.
57. Gonzalez-Maeso J., Ang R.L., Yuen T., Chan P., Weisstaub N.V., Lopez-Gimenez J.F., Zhou M., Okawa Y., Callado L.F., Milligan G., et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008, 452:93-97.
58. Grabrucker A.M., Schmeisser M.J., Schoen M., Boeckers T.M. Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol. 2011, 21:594-603.
59. Gross C., Hen R. The developmental origins of anxiety. Nat. Rev. Neurosci. 2004, 5:545-552.
60. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., Santarelli L., Beck S., Hen R. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002, 416:396-400.
61. Gutknecht L., Kriegebaum C., Waider J., Schmitt A., Lesch K.P. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur. Neuropsychopharmacol. 2009, 19:266-282.
62. Gutknecht L., Araragi N., Merker S., Waider J., Sommerlandt F.M., Mlinar B., Baccini G., Mayer U., Proft F., Hamon M., et al. Impacts of brain serotonin deficiency following Tph2 inactivation on development and raphe neuron serotonergic specification. PLoS ONE 2012, 7:e43157.
63. Halberstadt A.L., Lehmann-Masten V.D., Geyer M.A., Powell S.B. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology (Berl.) 2011, 215:81-92.
64. Hay-Schmidt A. The evolution of the serotonergic nervous system. Proc. Biol. Sci. 2000, 267:1071-1079.
65. Hendricks T., Francis N., Fyodorov D., Deneris E.S. The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J. Neurosci. 1999, 19:10348-10356.
66. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci. Biobehav. Rev. 2006, 30:203-214.
67. Holtmaat A., Svoboda K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 2009, 10:647-658.
68. Homberg J.R., Lesch K.P. Looking on the bright side of serotonin transporter gene variation. Biol. Psychiatry 2011, 69:513-519.
69. Hornung J.P., Fritschy J.M., Tork I. Distribution of two morphologically distinct subsets of serotoninergic axons in the cerebral cortex of the marmoset. J. Comp. Neurol. 1990, 297:165-181.
70. Inaba M., Maruyama T., Yoshimura Y., Hosoi H., Komatsu Y. Facilitation of low-frequency stimulation-induced long-term potentiation by endogenous noradrenaline and serotonin in developing rat visual cortex. Neurosci. Res. 2009, 64:191-198.
71. Jacobsen K.X., Czesak M., Deria M., Le Francois B., Albert P.R. Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo. J. Neurochem. 2011, 116:1066-1076.
72. Jansen F., Heiming R.S., Kloke V., Kaiser S., Palme R., Lesch K.P., Sachser N. Away game or home match: the influence of venue and serotonin transporter genotype on the display of offensive aggression. Behav. Brain Res. 2011, 219:291-301.
73. Jia Z., Lu Y., Henderson J., Taverna F., Romano C., Abramow-Newerly W., Wojtowicz J.M., Roder J. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learn. Mem. 1998, 5:331-343.
74. Jia Z., Lu Y.M., Agopyan N., Roder J. Gene targeting reveals a role for the glutamate receptors mGluR5 and GluR2 in learning and memory. Physiol. Behav. 2001, 73:793-802.
75. Jitsuki S., Takemoto K., Kawasaki T., Tada H., Takahashi A., Becamel C., Sano A., Yuzaki M., Zukin R.S., Ziff E.B., et al. Serotonin mediates cross-modal reorganization of cortical circuits. Neuron 2011, 69:780-792.
76. Jones K.A., Srivastava D.P., Allen J.A., Strachan R.T., Roth B.L., Penzes P. Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling. Proc. Natl. Acad. Sci. USA 2009, 106:19575-19580.
77. Kachroo A., Orlando L.R., Grandy D.K., Chen J.-F., Young A.B., Schwarzschild M.A. Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J. Neurosci. 2005, 25:10414-10419.
78. Keinan A., Clark A.G. Recent explosive human population growth has resulted in an excess of rare genetic variants. Science 2012, 336:740-743.
79. Kim H.S., Jang H.J., Cho K.H., Hahn S.J., Kim M.J., Yoon S.H., Jo Y.H., Kim M.S., Rhie D.J. Serotonin inhibits the induction of NMDA receptor-dependent long-term potentiation in the rat primary visual cortex. Brain Res. 2006, 1103:49-55.
80. Kim J., Jung S.Y., Lee Y.K., Park S., Choi J.S., Lee C.J., Kim H.S., Choi Y.B., Scheiffele P., Bailey C.H., et al. Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals. Proc. Natl. Acad. Sci. USA 2008, 105:9087-9092.
81. Kiyasova V., Fernandez S.P., Laine J., Stankovski L., Muzerelle A., Doly S., Gaspar P. A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei. J. Neurosci. 2011, 31:2756-2768.
82. Kloke V., Jansen F., Heiming R.S., Palme R., Lesch K.P., Sachser N. The winner and loser effect, serotonin transporter genotype, and the display of offensive aggression. Physiol. Behav. 2011, 103:565-574.
83. Knafo S., Esteban J.A. Common pathways for growth and for plasticity. Curr. Opin. Neurobiol. 2012, 22:405-411.
84. Kreienkamp H.J., Zitzer H., Gundelfinger E.D., Richter D., Bockers T.M. The calcium-independent receptor for alpha-latrotoxin from human and rodent brains interacts with members of the ProSAP/SSTRIP/Shank family of multidomain proteins. J. Biol. Chem. 2000, 275:32387-32390.
85. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
86. Le Francois B., Czesak M., Steubl D., Albert P.R. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 2008, 55:977-985.
87. LeDoux J. Rethinking the emotional brain. Neuron 2012, 73:653-676.
88. Lee E.J., Banerjee S., Zhou H., Jammalamadaka A., Arcila M., Manjunath B.S., Kosik K.S. Identification of piRNAs in the central nervous system. RNA 2011, 17:1090-1099.
89. Lesch K.P. Genetic alterations of the murine serotonergic gene pathway: the neurodevelopmental basis of anxiety. Handb. Exp. Pharmacol. 2005, 169:71-112.
90. Lesch K.P. Linking emotion to the social brain. The role of the serotonin transporter in human social behaviour. EMBO Rep. 2007, 8(Spec No):S24-S29.
91. Lesch K.P. When the serotonin transporter gene meets adversity: the contribution of animal models to understanding epigenetic mechanisms in affective disorders and resilience. Curr. Top. Behav. Neurosci. 2011, 7:251-280.
92. Lesch K.P., Selch S., Renner T.J., Jacob C., Nguyen T.T., Hahn T., Romanos M., Walitza S., Shoichet S., Dempfle A., et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol. Psychiatry 2011, 16:491-503.
93. Lesch K.P., Araragi N., Waider J., van den Hove D., Gutknecht L. Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012, 367:2426-2443.
94. Lesch K.P., Merker S., Reif A., Novak M. Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD. Eur. Neuropsychopharmacol. 2012, Published online August 29, 2012. 10.1016/j.euroneuro.2012.07.013.
95. Lewejohann L., Kloke V., Heiming R.S., Jansen F., Kaiser S., Schmitt A., Lesch K.P., Sachser N. Social status and day-to-day behaviour of male serotonin transporter knockout mice. Behav. Brain Res. 2010, 211:220-228.
96. Lionel A.C., Crosbie J., Barbosa N., Goodale T., Thiruvahindrapuram B., Rickaby J., Gazzellone M., Carson A.R., Howe J.L., Wang Z., et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci. Transl. Med. 2011, 3:95ra75.
97. Liu C., Deneris E.S. Transcriptional control of serotonin-modulated behavior and physiology. Neuropsychopharmacology 2011, 36:361-362.
98. Llado-Pelfort L., Santana N., Ghisi V., Artigas F., Celada P. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cereb. Cortex 2012, 22:1487-1497.
99. Lupski J.R., Belmont J.W., Boerwinkle E., Gibbs R.A. Clan genomics and the complex architecture of human disease. Cell 2011, 147:32-43.
100. Makino H., Malinow R. AMPA receptor incorporation into synapses during LTP: the role of lateral movement and exocytosis. Neuron 2009, 64:381-390.
101. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
102. Malinow R., Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 2002, 25:103-126.
103. Mansour-Robaey S., Mechawar N., Radja F., Beaulieu C., Descarries L. Quantified distribution of serotonin transporter and receptors during the postnatal development of the rat barrel field cortex. Brain Res. Dev. Brain Res. 1998, 107:159-163.
104. Maren S. Synaptic mechanisms of associative memory in the amygdala. Neuron 2005, 47:783-786.
105. Mathur B.N., Capik N.A., Alvarez V.A., Lovinger D.M. Serotonin induces long-term depression at corticostriatal synapses. J. Neurosci. 2011, 31:7402-7411.
106. Maya Vetencourt J.F., Sale A., Viegi A., Baroncelli L., De Pasquale R., O'Leary O.F., Castren E., Maffei L. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008, 320:385-388.
107. McClellan J., King M.C. Genetic heterogeneity in human disease. Cell 2010, 141:210-217.
108. Meijer O.C., Kortekaas R., Oitzl M.S., de Kloet E.R. Acute rise in corticosterone facilitates 5-HT(1A) receptor-mediated behavioural responses. Eur. J. Pharmacol. 1998, 351:7-14.
109. Millan M.J. MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues. Curr. Opin. Pharmacol. 2011, 11:11-22.
110. Millan M.J., Marin P., Bockaert J., Mannoury la Cour C. Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol. Sci. 2008, 29:454-464.
111. Miniaci M.C., Kim J.H., Puthanveettil S.V., Si K., Zhu H., Kandel E.R., Bailey C.H. Sustained CPEB-dependent local protein synthesis is required to stabilize synaptic growth for persistence of long-term facilitation in Aplysia. Neuron 2008, 59:1024-1036.
112. Moessner R., Marshall C.R., Sutcliffe J.S., Skaug J., Pinto D., Vincent J., Zwaigenbaum L., Fernandez B., Roberts W., Szatmari P., et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 2007, 81:1289-1297.
113. Murase S., Schuman E.M. The role of cell adhesion molecules in synaptic plasticity and memory. Curr. Opin. Cell Biol. 1999, 11:549-553.
114. Murphy D.L., Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 2008, 9:85-96.
115. Murphy D.G., Daly E., Schmitz N., Toal F., Murphy K., Curran S., Erlandsson K., Eersels J., Kerwin R., Ell P., et al. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am. J. Psychiatry 2006, 163:934-936.
116. Naisbitt S., Kim E., Tu J.C., Xiao B., Sala C., Valtschanoff J., Weinberg R.J., Worley P.F., Sheng M. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 1999, 23:569-582.
117. Navailles S., De Deurwaerdere P. Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology (Berl.) 2011, 213:213-242.
118. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., Lin C.F., Stevens C., Wang L.S., Makarov V., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245.
119. Nietzer S.L., Bonn M., Jansen F., Heiming R.S., Lewejohann L., Sachser N., Asan E.S., Lesch K.P., Schmitt A.G. Serotonin transporter knockout and repeated social defeat stress: impact on neuronal morphology and plasticity in limbic brain areas. Behav. Brain Res. 2011, 220:42-54.
120. Normann C., Clark K. Selective modulation of Ca(2+) influx pathways by 5-HT regulates synaptic long-term plasticity in the hippocampus. Brain Res. 2005, 1037:187-193.
121. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
122. O'Sullivan M.L., de Wit J., Savas J.N., Comoletti D., Otto-Hitt S., Yates J.R., Ghosh A. FLRT Proteins Are Endogenous Latrophilin Ligands and Regulate Excitatory Synapse Development. Neuron 2012, 73:903-910.
123. Ogren S.O., Eriksson T.M., Elvander-Tottie E., D'Addario C., Ekstrom J.C., Svenningsson P., Meister B., Kehr J., Stiedl O. The role of 5-HT(1A) receptors in learning and memory. Behav. Brain Res. 2008, 195:54-77.
124. Page D.T., Kuti O.J., Prestia C., Sur M. Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proc. Natl. Acad. Sci. USA 2009, 106:1989-1994.
125. Pagnamenta A.T., Khan H., Walker S., Gerrelli D., Wing K., Bonaglia M.C., Giorda R., Berney T., Mani E., Molteni M., et al. Rare familial 16q21 microdeletions under a linkage peak implicate cadherin 8 (CDH8) in susceptibility to autism and learning disability. J. Med. Genet. 2011, 48:48-54.
126. Pardo C.A., Eberhart C.G. The neurobiology of autism. Brain Pathol. 2007, 17:434-447.
127. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
128. Perroy J., Raynaud F., Homburger V., Rousset M.C., Telley L., Bockaert J., Fagni L. Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors. J. Biol. Chem. 2008, 283:6799-6805.
129. Persico A.M., Mengual E., Moessner R., Hall F.S., Revay R.S., Sora I., Arellano J., DeFelipe J., Gimenez-Amaya J.M., Conciatori M., et al. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J. Neurosci. 2001, 21:6862-6873.
130. Pessoa L. On the relationship between emotion and cognition. Nat. Rev. Neurosci. 2008, 9:148-158.
131. Phelps E.A. Emotion and cognition: insights from studies of the human amygdala. Annu. Rev. Psychol. 2006, 57:27-53.
132. Puig M.V., Artigas F., Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb. Cortex 2005, 15:1-14.
133. Qureshi I.A., Mehler M.F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 2012, 13:528-541.
134. Rajasethupathy P., Fiumara F., Sheridan R., Betel D., Puthanveettil S.V., Russo J.J., Sander C., Tuschl T., Kandel E. Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 2009, 63:803-817.
135. Rajasethupathy P., Antonov I., Sheridan R., Frey S., Sander C., Tuschl T., Kandel E.R. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell 2012, 149:693-707.
136. Ren-Patterson R.F., Cochran L.W., Holmes A., Sherrill S., Huang S.J., Tolliver T., Lesch K.P., Lu B., Murphy D.L. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J. Neurosci. Res. 2005, 79:756-771.
137. Ren-Patterson R.F., Cochran L.W., Holmes A., Lesch K.P., Lu B., Murphy D.L. Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell. Mol. Neurobiol. 2006, 26:755-780.
138. Rivero O., Sich S., Popp S., Schmitt A., Franke B., Lesch K.P. Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. Eur. Neuropsychopharmacol. 2012, Published online July 11, 2012. 10.1016/j.euroneuro.2012.06.009.
139. Romorini S., Piccoli G., Jiang M., Grossano P., Tonna N., Passafaro M., Zhang M., Sala C. A functional role of postsynaptic density-95-guanylate kinase-associated protein complex in regulating Shank assembly and stability to synapses. J. Neurosci. 2004, 24:9391-9404.
140. Rothe C., Gutknecht L., Freitag C.M., Tauber R., Franke P., Fritze J., Wagner G., Peikert G., Wenda B., Sand P., et al. Association of a functional -1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int. J. Neuropsychopharmacol. 2004, 7:189-192.
141. Rumpel S., LeDoux J., Zador A., Malinow R. Postsynaptic receptor trafficking underlying a form of associative learning. Science 2005, 308:83-88.
142. Saba R., Schratt G.M. MicroRNAs in neuronal development, function and dysfunction. Brain Res. 2010, 1338:3-13.
143. Salichon N., Gaspar P., Upton A.L., Picaud S., Hanoun N., Hamon M., De Maeyer E., Murphy D.L., Mossner R., Lesch K.P., et al. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J. Neurosci. 2001, 21:884-896.
144. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
145. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
146. Schumann G., Johann M., Frank J., Preuss U., Dahmen N., Laucht M., Rietschel M., Rujescu D., Lourdusamy A., Clarke T.K., et al. Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch. Gen. Psychiatry 2008, 65:826-838.
147. Si K., Giustetto M., Etkin A., Hsu R., Janisiewicz A.M., Miniaci M.C., Kim J.H., Zhu H., Kandel E.R. A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in aplysia. Cell 2003, 115:893-904.
148. Singh S.M., Castellani C., O'Reilly R. Autism meets schizophrenia via cadherin pathway. Schizophr. Res. 2010, 116:293-294.
149. Song N.N., Xiu J.B., Huang Y., Chen J.Y., Zhang L., Gutknecht L., Lesch K.P., Li H., Ding Y.Q. Adult raphe-specific deletion of Lmx1b leads to central serotonin deficiency. PLoS ONE 2011, 6:e15998.
150. Steinbeis N., Bernhardt B.C., Singer T. Impulse control and underlying functions of the left DLPFC mediate age-related and age-independent individual differences in strategic social behavior. Neuron 2012, 73:1040-1051.
151. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981, 6:557-618.
152. Strobel A., Gutknecht L., Zheng Y., Reif A., Brocke B., Lesch K.P. Allelic variation of serotonin receptor 1A function is associated with anxiety- and depression-related traits. J. Neural Transm. 2003, 110:1445-1453.
153. Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
154. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Sudhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
155. Talkowski M.E., Rosenfeld J.A., Blumenthal I., Pillalamarri V., Chiang C., Heilbut A., Ernst C., Hanscom C., Rossin E., Lindgren A.M., et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012, 149:525-537.
156. Tomasi D., Volkow N.D. Abnormal functional connectivity in children with attention-deficit/hyperactivity disorder. Biol. Psychiatry 2012, 71:443-450.
157. Tu J.C., Xiao B., Naisbitt S., Yuan J.P., Petralia R.S., Brakeman P., Doan A., Aakalu V.K., Lanahan A.A., Sheng M., et al. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 1999, 23:583-592.
158. van den Hove D.L., Jakob S.B., Schraut K.G., Kenis G., Schmitt A.G., Kneitz S., Scholz C.J., Wiescholleck V., Ortega G., Prickaerts J., et al. Differential effects of prenatal stress in 5-Htt deficient mice: towards molecular mechanisms of gene x environment interactions. PLoS ONE 2011, 6:e22715.
159. Volkow N.D., Wang G.J., Tomasi D., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F.W., Fowler J.S., Logan J., Wong C.T., et al. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J. Neurosci. 2012, 32:841-849.
160. Wang K., Zhang H., Ma D., Bucan M., Glessner J.T., Abrahams B.S., Salyakina D., Imielinski M., Bradfield J.P., Sleiman P.M., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
161. Wang L.W., Berry-Kravis E., Hagerman R.J. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 2010, 7:264-274.
162. Waselus M., Galvez J.P., Valentino R.J., Van Bockstaele E.J. Differential projections of dorsal raphe nucleus neurons to the lateral septum and striatum. J. Chem. Neuroanat. 2006, 31:233-242.
163. Wellman C.L., Izquierdo A., Garrett J.E., Martin K.P., Carroll J., Millstein R., Lesch K.P., Murphy D.L., Holmes A. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J. Neurosci. 2007, 27:684-691.
164. Williams M.E., de Wit J., Ghosh A. Molecular mechanisms of synaptic specificity in developing neural circuits. Neuron 2010, 68:9-18.
165. Williams N.M., Zaharieva I., Martin A., Langley K., Mantripragada K., Fossdal R., Stefansson H., Stefansson K., Magnusson P., Gudmundsson O.O., et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376:1401-1408.
166. Williams M.E., Wilke S.A., Daggett A., Davis E., Otto S., Ravi D., Ripley B., Bushong E.A., Ellisman M.H., Klein G., et al. Cadherin-9 regulates synapse-specific differentiation in the developing hippocampus. Neuron 2011, 71:640-655.
167. Williams N.M., Franke B., Mick E., Anney R.J., Freitag C.M., Gill M., Thapar A., O'Donovan M.C., Owen M.J., Holmans P., et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am. J. Psychiatry 2012, 169:195-204.
168. Wolf C., Linden D.E. Biological pathways to adaptability-interactions between genome, epigenome, nervous system and environment for adaptive behavior. Genes Brain Behav. 2012, 11:3-28.
169. Wylie C.J., Hendricks T.J., Zhang B., Wang L., Lu P., Leahy P., Fox S., Maeno H., Deneris E.S. Distinct transcriptomes define rostral and caudal serotonin neurons. J. Neurosci. 2010, 30:670-684.
170. Xiao B., Tu J.C., Worley P.F. Homer: a link between neural activity and glutamate receptor function. Curr. Opin. Neurobiol. 2000, 10:370-374.
171. Xu J., Zhu Y., Contractor A., Heinemann S.F. mGluR5 has a critical role in inhibitory learning. J. Neurosci. 2009, 29:3676-3684.
172. Yamagata M., Sanes J.R., Weiner J.A. Synaptic adhesion molecules. Curr. Opin. Cell Biol. 2003, 15:621-632.
173. Yuen E.Y., Jiang Q., Chen P., Gu Z., Feng J., Yan Z. Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. J. Neurosci. 2005, 25:5488-5501.
174. Yuen E.Y., Jiang Q., Chen P., Feng J., Yan Z. Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex. J. Biol. Chem. 2008, 283:17194-17204.